This meeting took place in 2019
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Helminths: New Insights from Immunity to Global Health (T4)
Organizer(s) De' Broski Herbert, P'ng Loke, Nicola L. Harris and Frank Brombacher
December 8—12, 2019
Southern Sun Cape Sun • Cape Town, Western Cape South Africa
Discounted Abstract Deadline: Aug 8, 2019
Abstract Deadline: Sep 24, 2019
Scholarship Deadline: Aug 8, 2019
Discounted Registration Deadline: Oct 10, 2019
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
Summary of Meeting:
Parasitic worms, or helminths, infect roughly one in five people on the planet and cause pathology in hundreds of millions. Given the global impact on human health and welfare, there is a great need to develop novel therapies and/or vaccines that target helminths. In addition, the unique nature of how these parasites interact with their hosts has brought tremendous insight into the mammalian immune system. Experimental studies of helminth infection have led to the identification of new cell types involved in type 2 immunity, including innate lymphoid cells, tuft cells, and new roles for neurons, in addition to revealing novel pathways of tissue repair and immune-modulation. The interactions of helminths with the microbiome has also come to light in recent years. This conference will highlight some of the most impactful advances in the fields of helminth genomics, helminth biology, vaccine design and host protective immunity, in addition to new discoveries highlighting the ability of these organisms to modulate the immune system, human disease and the microbiome.
View Meeting Program
Parasitic worms, or helminths, infect roughly one in five people on the planet and cause pathology in hundreds of millions. Given the global impact on human health and welfare, there is a great need to develop novel therapies and/or vaccines that target helminths. In addition, the unique nature of how these parasites interact with their hosts has brought tremendous insight into the mammalian immune system. Experimental studies of helminth infection have led to the identification of new cell types involved in type 2 immunity, including innate lymphoid cells, tuft cells, and new roles for neurons, in addition to revealing novel pathways of tissue repair and immune-modulation. The interactions of helminths with the microbiome has also come to light in recent years. This conference will highlight some of the most impactful advances in the fields of helminth genomics, helminth biology, vaccine design and host protective immunity, in addition to new discoveries highlighting the ability of these organisms to modulate the immune system, human disease and the microbiome.
View Meeting Program
Scholarships/Awards
National Institute of Allergy and Infectious Diseases (NIAID)/National Center for Advancing Translational Sciences (NCATS) Scholarship Recipients
Aldian Irma Amaruddin
Leiden University Medical Center, Netherlands
Naina Arora
Indian Institute of Technology Mandi, India
Pritesh Desai
Washington University in St. Louis, USA
Taryn A. McLaughlin
Emory University, USA
Juan Manuel Ortiz Wilczyñski
IMEX - CONICET - Academia Nacional de Medicina, Argentina
Shuchi Smita
Institute of Life Sciences, India
Aidil Zikri Zaini
Monash University, Australia
Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Nada Abdel Aziz
Cairo University, Egypt
Abdulazeez Aderemi Abubakar
University of Medical Sciences, Nigeria
Adeyinka Samuel Adedokun
Ladoke Akintola University of Technology, Nigeria
Olusegun Adelowo Adefioye
Ladoke Akintola University of Technology, Nigeria
Akeem Abiodun Akindele
Ladoke Akintolola University of Technology, Nigeria
Jacqueline Araujo Fiuza
René Rachou Institute, Brazil
Oloyede Samuel Bolaji
Ladoke Akintola University of Technology, Nigeria
Moses Egesa
MRC/UVRI & LSHTM Uganda Research Unit, Uganda
Cristina Toscano Fonseca
René Rachou Research Institute-Fiocruz, Brazil
Soraya Gaze Jangola
Fiocruz - Instituto Rene Rahcou, Brazil
Wiliam Horsnell
University of Cape Town, South Africa
Juan M. Inclan Rico
Rutgers New Jersey Medical School, USA
Severin Donald Kamdem
University of Utah, USA
Charu Kohli
University of Delhi, India
Paballo Pertunia Mosala
University of Cape Town, South Africa
Yoanne Darelle Mouwenda
Leiden University Medical Center, Netherlands
Thabo RV Mpotje
Africa Health Research Institute, South Africa
Gyaviira Nkurunungi
MRC/UVRI and LSHTM Uganda Research Unit, Uganda
Justin Nono Komguep
Institute of Medical Research and Medicinal Plant Studies, IMPM, Cameroon
Adefunke Esther Ogunkanbi
University of Manchester, UK
Folasade Josephine Ojo
Redeemer’s University, Nigeria
Jackson Onywera
Mt. Kenya University, Kenya
Olawunmi Rashidat Oyerinde
Mountain Top University, Nigeria
Oyebola O. Oyesola
Cornell University, USA
Anuradha Rajamanickam
National Institute for Research in Tuberculosis, India
Daniel Andrés Real
Instituto de Química de Rosario, Argentina
Maria Priscila Saracino
Buenos Aires University, Argentina
Murilo Sena Amaral
Instituto Butantan, Brazil
Camila de Oliveira Silva e Souza
School of Pharmaceutical Sciences of Ribeirão Preto, Brazil
MD Hasanuzzaman Talukder
Bangladesh Agricultural University, Bangladesh
Manuela Renee Verastegui
University Peruana Cayetano Heredia, Peru
Cecilia Celeste Vila
University of Buenos Aires, Argentina
Bridgious Walusimbi
MRC/Uganda Virus Research Institute, Uganda